Medical Device CRO Market is estimated to be worth USD 15.7 billion in 2030

RootsAnalysis is pleased to announce the publication of its recent study, titled, “MedicalDevice CRO Market, 2020-2030”.

Thereport features an extensive study of the current market landscape and futureopportunities of contract research service providers focused on medical devices.The study also features an in-depth analysis, highlighting the capabilities ofthe various stakeholders engaged in this domain, across different regions ofthe globe. In addition to other elements, the study includes:

·       A detailed review of the overall landscape ofmedical device CROs.

·       An elaborate discussion on the variousguidelines established by major regulatory bodies for medical device approvalacross North America, Europe, and Asia-Pacific and rest of the world.

·       Elaborate profiles of key players thatspecialize in offering services for both clinical and preclinical stagedevelopment of medical devices.

·       An analysis highlighting the key performanceindicators used by sponsor companies to evaluate service providers engaged inthis domain

·       A competitive benchmarking, highlighting thekey focus areas of small, mid-sized and large companies, comparing theirexisting capabilities within and beyond their respective peer groups.

·       A detailed brand positioning analysis ofleading industry players (shortlisted on the basis of strength of serviceportfolio).

·       A detailed geographical clinical trialanalysis of ongoing and planned studies related to medical devices.

·       A detailed analysis of the mergers andacquisitions that have taken place in this domain during the period 2015-2020.

·       A survey analysis featuring inputs solicitedfrom various experts who are directly / indirectly involved in providingcontract research services to medical device developers.

·       A discussion on affiliated trends, keydrivers and challenges, under a SWOT framework, which are likely to impact theindustry’s evolution.

·       An elaborate discussion on the futureopportunities / trends for the medical device outsourcing market that arelikely to influence the growth of this domain over the coming years.

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

Phaseof Development

·       Clinical

·       Preclinical

Typesof Preclinical Services Offered

·       Biocompatibility testing

·       Sterility and microbiology testing

·       Material characterization and analyticalservices

·       Others

Typesof Clinical Services Offered

·       Clinical trial management

·       Data management

·       Regulatory affairs management

·       Consulting

·       Others

DeviceClass

·       Class I medical devices

·       Class II medical devices

·       Class III medical devices

TargetTherapeutic Area

·       CNS disorders

·       Cardiovascular disorders

·       Oncological disorders

·       Bone disorders

·       Respiratory disorders

·       Pain management disorders

·       Ophthalmic disorders

·       Psychological disorders

·       Metabolic disorders

·       Others

Requestfor Customization:

https://www.rootsanalysis.com/reports/226/request-customization.html

KeyGeographical Regions

·       North America

·       Europe

·       Asia-Pacific

·       Rest of the World

Transcriptsof interviews held with the following senior level representatives ofstakeholder companies

·       Lajos Sarosi (Chief Executive Officer andCo-founder, HungaroTrial)

·       Christopher Rupp (Vice President of GlobalMarketing and Commercial Operations, NAMSA)

·       Christian Wolflehner (General Manager, CWResearch & Management)

·       Troy Mccall (Chief Operating Officer,CROMSOURCE)

·       Nazish Urooj (Senior manager, Medical &Clinical Operations, Metrics Research)

·       C. Omprakash (Technical Director and Partner,Vyomus Consulting)

·       Tania Persson (Director of BusinessDevelopment, A+ Science)

·       Alexa Foltin-Mertgen (Business DevelopmentManager, AtoZ-CRO)

Keycompanies covered in the report

·       Avania (formerly known as Factory CRO)

·       Charles River Laboratories

·       Clinlogix

·       CROMSOURCE

·       CSSi LifeSciences™

·       Eurofins Medical Device Testing

·       genae

·       IMARC Research

·       IQVIA

·       Medpace

·       NAMSA

·       Qserve Group

·       Regulatory and Clinical Research Institute(now a part of Covance)

·       WuXi AppTec

Requestfor PDF Sample:

https://www.rootsanalysis.com/reports/226/request-sample.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growing businessneeds, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

AlsoVisit Our Latest Publication

Human Microbiome Market

In Silico / Computer-Aided DrugDiscovery Services Market

Antibody Contract Manufacturing Market

Biopharma Contract Manufacturing Market